- Home
- MOLN vs EFSI Comparison
MOLN vs EFSI Comparison
Compare MOLN & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- EFSI
- Stock Information
- Founded
- MOLN 2004
- EFSI 1881
- Country
- MOLN Switzerland
- EFSI United States
- Employees
- MOLN N/A
- EFSI N/A
- Industry
- MOLN
- EFSI Major Banks
- Sector
- MOLN
- EFSI Finance
- Exchange
- MOLN Nasdaq
- EFSI Nasdaq
- Market Cap
- MOLN 183.2M
- EFSI 176.7M
- IPO Year
- MOLN 2021
- EFSI N/A
- Fundamental
- Price
- MOLN $3.97
- EFSI $31.20
- Analyst Decision
- MOLN
- EFSI Strong Buy
- Analyst Count
- MOLN 0
- EFSI 2
- Target Price
- MOLN N/A
- EFSI $40.00
- AVG Volume (30 Days)
- MOLN 4.2K
- EFSI 42.2K
- Earning Date
- MOLN 03-06-2025
- EFSI 01-01-0001
- Dividend Yield
- MOLN N/A
- EFSI 3.96%
- EPS Growth
- MOLN N/A
- EFSI 62.57
- EPS
- MOLN N/A
- EFSI 4.32
- Revenue
- MOLN $5,484,562.00
- EFSI $69,938,000.00
- Revenue This Year
- MOLN N/A
- EFSI $27.21
- Revenue Next Year
- MOLN $528.57
- EFSI N/A
- P/E Ratio
- MOLN N/A
- EFSI $7.23
- Revenue Growth
- MOLN N/A
- EFSI 10.80
- 52 Week Low
- MOLN $3.32
- EFSI $27.02
- 52 Week High
- MOLN $12.70
- EFSI $36.93
- Technical
- Relative Strength Index (RSI)
- MOLN 48.67
- EFSI N/A
- Support Level
- MOLN $3.57
- EFSI N/A
- Resistance Level
- MOLN $3.99
- EFSI N/A
- Average True Range (ATR)
- MOLN 0.31
- EFSI 0.00
- MACD
- MOLN 0.04
- EFSI 0.00
- Stochastic Oscillator
- MOLN 46.46
- EFSI 0.00
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About EFSI Eagle Financial Services Inc Common Stock
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending, and Wealth Management. It generates a majority of its revenue from the Community Banking segment.